Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma.
Weppler AM, Pattison A, Bhave P, De Ieso P, Raleigh J, Hatzimihalis A, Gill AJ, Balachander S, Callahan J, Chua M, Au-Yeung G, McArthur GA, Hicks RJ, Tothill RW, Sandhu S.
Weppler AM, et al. Among authors: mcarthur ga.
J Immunother Cancer. 2020 Oct;8(2):e000700. doi: 10.1136/jitc-2020-000700.
J Immunother Cancer. 2020.
PMID: 33060145
Free PMC article.